The CRM diseases industry grows at 4.8% CAGR to US$451.87 billion by 2033, propelled by diagnostics innovations and population aging. Learn about metabolic's 23% share, global shifts toward preventive care, and opportunities in expanding therapeutics for interconnected chronic conditions. https://finance.yahoo.com/news/cardiovascular-renal-metabolic-crm-diseases-143500544.html